Cascade Investment Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-320
Closed -$17.3K – 153
2023
Q1
$17.3K Buy
+320
New +$17K 0.01% 196
2022
Q3
– Sell
-420
Closed -$21.2K – 154
2022
Q2
$21.2K Hold
420
– – 0.02% 190
2022
Q1
$25.6K Hold
420
– – 0.02% 202
2021
Q4
$27.7K Hold
420
– – 0.02% 195
2021
Q3
$26.4K Hold
420
– – 0.02% 192
2021
Q2
$25.3K Hold
420
– – 0.02% 197
2021
Q1
$23.1K Hold
420
– – 0.02% 199
2020
Q4
$22.9K Buy
+420
New +$22K 0.02% 194

Other funds holding IHI

Cascade Investment Advisors's IHI Position: Q2 2023 in Review

Cascade Investment Advisors sold out of iShares US Medical Devices ETF (IHI) in Q2 2023, closing a stake of 320 shares — an estimated $17.3K sold.

Cascade Investment Advisors first reported a position in IHI in Q4 2020 and held it in 8 quarters. The position peaked at $27.7K in Q4 2021. 585 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • Cascade Investment Advisors reported no remaining iShares US Medical Devices ETF position as of Q2 2023 after selling out during the quarter.
  • Cascade Investment Advisors sold 320 iShares US Medical Devices ETF shares in Q2 2023, an estimated $17.3K.
  • Cascade Investment Advisors first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 8 quarters.
  • Cascade Investment Advisors's iShares US Medical Devices ETF position peaked at $27.7K in Q4 2021.
  • 585 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.